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Objectives: To identify the extent to which patients accept the measure of cost 
sharing fee (5€ ) in public primary health care units (health centers and hospitals’ 
outpatient departments) as well as to investigate whether patients perceive the 
potential benefits of the measure for the quality improvement of provided health 
care. MethOds: The study population consisted of 1260 people, who used public 
primary health care units. A structured questionnaire was used, including ques-
tions for patients’ demographic characteristics, their attitude regarding the cost 
sharing mechanism (compliance, perception of the benefits for health services 
upgrade etc), and their level of satisfaction with the provided services. Results: 
The implementation of cost sharing mechanism was positively accepted by 30% 
of respondents. Approximately 90% of the respondents, who expressed positive 
opinion for the implementation of the mechanism, considered that it would provide 
financial support to health units. Among the respondents who expressed negative 
opinion for the measure, 95% believed that health services should be public and free 
for everyone, 83% expressed lack of confidence that the measure aims at upgrading 
the provided services, 78% believed that the insurance contributions they already 
pay are high and 67% stated no financial comfort. The negative opinions were more 
frequent among people with lower socio-economic profile and those who have used 
health centers (p< 0.06). Respondents with higher socio-economic profile, coming 
from urban areas and respondents who were very satisfied with health services 
had statistically significantly greater possibility to express positive opinion for the 
measure. cOnclusiOns: Low socio-economic profile is negatively associated with 
the acceptance of the implementation of cost sharing mechanism, while high satis-
faction with services is positively associated with the acceptance of the mechanism. 
The majority of those, who expressed positive opinion for the measure, consider it 
as a contribution to the enhancement of health services.
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Objectives: Financial incentives or Pay-for-Performance (P4P) have become a 
common approach to improve the quality in health care. Although the effective-
ness is mixed, more and more P4P initiatives are implemented. Besides the desired 
effects of quality improvement, a growing number of evaluations show that finan-
cial incentives lead to unintended consequences. Therefore this study analyses 
negative effects of P4P. MethOds: On the basis of a systematic review of system-
atic reviews regarding P4P in health care (nine systematic reviews included that 
evaluate 75 different primary studies; Methodological quality assessment using the 
AMSTAR checklist) an additional hand search was conducted to identify evidence of 
unintended consequences of P4P. Results: Both theory and evidence of financial 
incentives demonstrate the potential of negative effects. Risk selection is identified 
in six reviews: Patients could get selected due to their severity of illness in order 
to achieve quality targets with minimum effort (cherry picking); Physicians will 
focus on indicators or aspects of care that are linked to payments (teaching to the 
test). Focussing on incentivized indicators could lead to quality decrease in non-
incentivized indicators (negative spillover effects), assessed in four reviews. Five 
reviews show that physicians could game the P4P program by reporting incorrect 
results and therefore increase their payments (gaming). Furthermore, improvements 
can be the result of better documentation and not actual quality improvements (four 
reviews). Finally one review identified crowding out of intrinsic motivation due to 
financial incentives. cOnclusiOns: The available evidence shows that P4P can 
result in unintended consequences. Evaluations of P4P should include these effects 
in order to assess an overall effect and thereby determine the effectiveness of P4P. 
To avoid negative effects it is important to consider the potential of unintended 
consequences and develop appropriate solutions.
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Objectives: Home care (nursing) was introduced into the Hungarian basic health 
insurance package in 1996. The aim of our study is to analyze the geographical ine-
qualities in the access to and utilization of that services in Hungary. MethOds: Data 
were derived from the nationwide administrative dataset of the National Health 
Insurance Fund Administration (OEP), the only health care financing agency in 
Hungary. The geographical inequalities in home care (nursing) services were meas-
ured by the number patients, visits and reimbursement according to 20 Hungarian 
counties. We analyzed the year 2011. Results: The national average number of 
patients was 51 patients / 10000 population. We found the highest patient number 
in county Zala (67), Jász-Nagykun-Szolnok (63) and Baranya (62), while the lowest 
number in county Békés (43), Somogy (43) and Szabolcs-Szatmár-Bereg (28). The 
national average number of home visits was 1193 visits / 10000 population. We found 
the highest number of visits in county Nógrád (1494), Tolna (1385) and Fejér (1377), 
while the lowest number in county Somogy (1138), Csongrád (1106) and Szabolcs-
Szatmár-Bereg (678). The national average of reimbursement per patient was 65345 
Objectives: Electronic-prescribing (E-prescribing) in comparison to manual (“by 
hand”) generation, transmission and filling of prescriptions is thought to substan-
tially lower the risks of inaccuracy and therefore reduce associated health care 
resource use and costs. The purpose of this work is to describe the current state of 
e-prescribing systems implementation in Denmark, Germany, Italy, Poland, United 
Kingdom (UK) and United States (USA), and to assess present evidence of its influ-
ence on health care. MethOds: A systematic review supplemented by additional 
hand-search was conducted to find relevant articles. Medline, Embase, The Cochrane 
Library and Scopus were searched. Quality was assessed on the basis of PRISMA, 
MOOSE and STROBE checklists and West 2002 recommendations. Results: Thirty-
one relevant full texts were identified during systematic review, and then as a result 
of hand-search, 5 publications were added. E-prescribing varies considerably across 
these countries. It is currently voluntary in Germany, Italy and United States. In 
United Kingdom the system is implemented except for electronic signature. In 
Denmark e-prescribing is mandatory for primary care providers. Model implemen-
tation in Poland is expected to take place in 2014. Of these 36 sources, 4 articles 
assessing e-prescribing were of the highest quality, as judged using the assessment 
methods. Positive influence on medical visits frequency, quality of care, patient 
satisfaction, prescription errors frequency, and prescriber-pharmacy-patient com-
munication was described in literature; most studies were conducted in the UK 
and USA. No data about effects of implementation for Germany, Italy, Denmark and 
Poland were found. cOnclusiOns: Implementation of e-prescribing is in process 
in the majority of described countries. Although few studies exist that definitely 
demonstrate positive impact of e-prescribing on health care, gathered papers do 
indicate positive effects. More comprehensive assessments would be valuable in 
showing the attributes of e-prescribing that are most valuable, and those that may 
be strengthened.
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Objectives: To review, describe and assess models of drug safety monitoring in 
England, Poland, Italy, Germany, Denmark and in the United States and prepare 
recommendations useful in health authorities decision-making process. MethOds: 
A review of documents, materials and information published on national medicines 
agencies as well as WHO’s statements was conducted, supplemented by hand-
search of literature. Results: The advantages and disadvantages of described phar-
macovigilance schemes in selected countries has been discussed. The gathered data, 
related i.a. to the level of adverse drug reaction reporting in different countries, was 
used to assess the efficacy of national reporting process. Moreover our research 
allowed us to value the formula of pharmacovigilance schemes as well as the atti-
tudes of health care professionals and patients towards it. cOnclusiOns: Although 
the majority of compared countries are European Union members bound to respect 
the same acts of European law, there are still many significant differences met in 
Pharmacovigilance practice reflecting in the level of adverse reaction reporting. 
These differences may be found as the treatment of newly registered medicines, 
data availability and transparency of procedures within the agencies or the relation-
ship between health authorities and potential reporters. A set of recommendations 
has been prepared related to special treatment of new medicines, creating aware-
ness of importance of pharmacovigilance in health care (hospitals, pharmacies), 
changing the attitude to risk aspects, transparency of safety monitoring practice 
and patients’ enrollment. The implication of our proposals could help to amend the 
pharmacovigilance systems in all discussed countries.
PHP58
sPecific Attributes of PHArmAceuticAl cAre in englAnd, PolAnd, 
germAny, denmArk, itAly And united stAtes
Hermanowski T.R.1, Duleba D.1, Krancberg A.N.1, Szafraniec-Burylo S.I.2, Pashos C.L.3
1Medical University of Warsaw, Warsaw, Poland, 2National Institute of Public Health – National 
Institute of Hygiene, Warsaw, Poland, 3Evidera, Lexington, MA, USA
Objectives: To describe existing models of pharmaceutical care (PC) in England, 
Poland, Germany, Denmark, Italy and United States and to indicate similarities 
and specific attributes meant as differences (from the whole system point of view), 
identifying possibly promising solutions (promising means having preliminary or 
probably positive results described in found literature). MethOds: A systematic 
and non-systematic literature review in Medline, Embase, Scopus and the Cochrane 
Library was performed. Quality of publications was critically appraised. Results: 
The review identified 48 full texts. The majority of papers were of moderate quality 
(PRISMA, MOOSE or STROBE checklists) and intermediate consistency, coherence 
and strength (West 2002). In chosen countries differences in the definition of PC 
have been noticed and therefore often it is difficult to find similarities. Although in 
some countries like England and the US, PC is firmly established and comparable 
with one another, in other it is very heterogeneous. Mainly in Central and Eastern 
Europe (CEE), especially in Poland, it is offered to a very limited extent or only pilot 
implementations exist. Four types of PC models have been distinguished: Anglo-
Saxon, Scandinavian, German and Italian. Specific attribute of English PC is division 
into essential, advanced and enhanced services. American pharmacists provid-
ing this service must be highly specialized. Danish system focuses on identifying, 
solving and prevention of drug-related problems. In Germany family pharmacy 
concept emerged. Pivotal point of Italian system is hospital PC. Identified promis-
ing solutions found in some countries were i.a. Drug Utilization Review, disease 
management programs or medicines use review. cOnclusiOns: Identical PC con-
cept may be difficult to introduce in all EU Member States, due to differences in 
health systems. However, some identified, promising actions should be considered 
by decision makers and providers, as well as implementing PC to a sufficient extent 
in CEE countries.
